Effects of a synthetic vitamin D analog, ED-71, on bone dynamics and strength in cancellous and cortical bone in prednisolone-treated rats
Yuzo Tanaka
Department of Orthopedic Surgery, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
Search for more papers by this authorCorresponding Author
Dr. Toshitaka Nakamura
Department of Orthopedic Surgery, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
Department of Orthopedic Surgery University of Occupational and Environmental Health 1-1 Iseigaoka, Yahatanishi-Ku Kitakyushu-807, JapanSearch for more papers by this authorSatoshi Nishida
Department of Orthopedic Surgery, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
Search for more papers by this authorKatsumi Suzuki
Department of Orthopedic Surgery, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
Search for more papers by this authorSatoshi Takeda
Fuji-Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd., Shizuoka, Japan
Search for more papers by this authorKatsuhiko Sato
Fuji-Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd., Shizuoka, Japan
Search for more papers by this authorYasuho Nishii
Fuji-Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd., Shizuoka, Japan
Search for more papers by this authorYuzo Tanaka
Department of Orthopedic Surgery, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
Search for more papers by this authorCorresponding Author
Dr. Toshitaka Nakamura
Department of Orthopedic Surgery, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
Department of Orthopedic Surgery University of Occupational and Environmental Health 1-1 Iseigaoka, Yahatanishi-Ku Kitakyushu-807, JapanSearch for more papers by this authorSatoshi Nishida
Department of Orthopedic Surgery, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
Search for more papers by this authorKatsumi Suzuki
Department of Orthopedic Surgery, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
Search for more papers by this authorSatoshi Takeda
Fuji-Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd., Shizuoka, Japan
Search for more papers by this authorKatsuhiko Sato
Fuji-Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd., Shizuoka, Japan
Search for more papers by this authorYasuho Nishii
Fuji-Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd., Shizuoka, Japan
Search for more papers by this authorAbstract
To determine the action of corticosteroid on bone metabolism and assess the effects of a synthetic vitamin D analog, ED-71, on them, 56 SD rats, 8 weeks of age, were assigned to seven groups of eight animals each. Group 1 was the basal control. Group 2 was the nontreated control. Groups 3–7 were given prednisolone at 30 mg/kg of body weight (BW) twice a week and concomitantly administered ED-71 with respective doses of 0, 0.0125, 0.025, 0.05, and 0.1 μg/kg of BW for 12 weeks. In group 3, urinary calcium (U-Ca) and deoxypyridinoline (U-Dpy) were significantly increased compared with group 2. In groups 4–7, U-Ca values were increased but U-Dpy values were dose-dependently decreased. Age-dependent increases in the parameter values of BMD, compressive strength, trabecular bone volume (BV/TV), and trabecular thickness (Tb.Th) of the lumbar body were significantly suppressed in group 3 but dose-dependently increased in groups 4–7, and the values of group 7 exceeded those of group 2. The parameters of bone mineral density (BMD) and the bending strength of the femur in groups 4–7 were larger than the values in group 3 but did not reach the levels of group 2. The trabecular bone formation rate (BFR/BS) of the lumbar body measured by calcein labeling in group 3 was reduced when compared with group 2, but the values were not further decreased in groups 4–7. The perimeter ratios of double labels over single labels (dLS/sLS) greatly decreased by prednisolone, were dose-dependently increased to the level of the normal control by ED-71. Double-labeled perimeters and the dLS/sLS ratios were also increased in the periosteal envelope of the midfemur. These findings clearly demonstrate that prednisolone administration affects the age-related changes in bone metabolism, and ED-71 administration counteracts the effects by increasing intestinal calcium absorption, reducing bone resorption, and enhancing mineralization. The action of ED-71, however, seems to be less potent in the cortical bone.
References
- 1 Curtiss PH, Clark WS, Herndon CH 1954 Vertebral fractures resulting from prolonged cortisone and corticotropin therapy. JAMA 156: 467–469.
- 2 Adinoff AD, Hollister JR 1983 Steroid-induced fractures and bone loss in patients with asthma. New Engl J Med 309: 265–268.
- 3 Sambrook P, Birmingham J, Kempler S, Kelly P, Eberl S, Pocock N, Yeates M, Eisman J 1990 Corticoid effects on proximal femur bone loss. J Bone Miner Res 5: 1211–1216.
- 4 Bressot C, Meunier PJ, Chapuy MC, Lejeune E, Edouard C, Darby AJ 1979 Histomorphomtric profile, pathophysiology and reversibility of corticosteroid-induced osteoporosis. Metabol Bone Dis Rel Res 1: 303–311.
- 5 Dietrich JW, Canalis EM, Maina DM, Raisz LG 1979 Effect of glucocorticoids on fetal rat bone collagen synthesis in vitro. Endocrinology 104: 715–721.
- 6 Sambrook PN, Eisman JA, Champion GD, Pocock NA 1988 Sex hormone status and osteoporosis in postmenopausal women with rheumatoid arthritis. Arthritis Rhem 31: 973–978.
- 7 Crilly R, Cawood M, Marshall DH, Nordin BEC 1978 Hormonal status in normal, osteoporotic and corticosteroidtreated postmenopausal women. J Roy Soc Med 71: 733–736.
- 8 Sakakura M, Takebe K, Nakagawa S 1975 Inhibition of luteinizing hormone secretion induced by synthetic LRH by longterm treatment with glucocorticoids in human subjects. J Clin Endocrinol Metab 40: 774–779.
- 9 Hsueh AJ, Erickson GF 1978 Glucocorticoid inhibition of FSH-induced estrogen production in cultured rat granulosa cells. Steroids 32: 639–648.
- 10 Schaison G, Durand F, Mowszowicz I 1978 Effect of glucocorticoids on plasma testosterone in men. Acta Endocrinol (Copenhagen) 89: 126–131.
- 11 MacAdams MR, White RH, Mowszowicz I 1978 Reduction of serum testosterone levels during chronic glucocorticoid therapy. Ann Intern Med 104: 648–651.
- 12 Reid IR, Katz JM, Ibbertson HK, Gray DH 1986 The effects of hydrocortisone, parathyroid hormone and the bisphosphonate, APD, on bone resorption in neonatal mouse calvaria. Calcif Tissue Int 38: 38–43.
- 13 Peck WA 1984 The effects of glucocoticoids on bone cell metabolism and function. Adv Exp Med 171: 111–119.
- 14 Gennari C 1985 Glucocorticoids and bone. In: WA Peck (ed.) Bone and Mineral Research/3. Elsevier, Amsterdam, pp. 213–231.
- 15 Dempster DW, Alrot MA, Meunier PJ 1983 Mean wall thickness and formation periods of trabecular bone packets corticosteroid-induced osteoporosis. Calcif Tissue Int 35: 410–417.
- 16 Dempster DW 1989 Bone histomorphometry in glucocorticoid-induced osteoporosis. J Bone Miner Res 4: 137–141.
- 17 Hahn TJ, Halstead LR, Teitelbaum SL, Hahn BH 1979 Altered mineral metabolism in glucocorticoid-induced osteopenia. Effects of 25-hydroxyvitamin D administration. J Clin Invest 64: 655–665.
- 18 Condon JR, Nassim JR, Dent CE, Hilb A, Stainthorpe EM 1978 Possible prevention and treatment of steroid-induced ostcoporosis. Postgrad Med J 54: 249–252.
- 19 Reid IR, Ibbertson HK 1986 Calcium supplements in the prevention of steroid-induced osteoporosis. Am J Clin Nutr 44: 287–290.
- 20 Ringe JD, Welzel D 1987 Salmon calcitonin in the therapy of corticoid-induced osteoporosis. Eur J Clin Pharmacol 33: 35–39.
- 21 Reid IR, Heap SW, King AR, Ibbertson HK 1988 Two-year follow-up of biphosphonate (APD) treatment in steroid osteoporosis (letter). Lancet 2: 1144.
- 22 Grecu EO, Weinshelbaum A, Simmons R 1990 Effective therapy of glucocorticoid-induced osteoporosis with medroxyprogesterone acetate. Calcif Tissue Int 46: 294–299.
- 23 Lukert BP, Johnson BE, Robinson RG 1992 Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss. J Bone Miner Res 7: 1063–1068.
- 24 Faugere MC, Okamoto S, DeLuca HF, Malluche HH 1986 Calcitriol corrects bone loss induced by oophorectomy in rats. Am J Physiol 250: E35–E38.
- 25 Malluche HH, Matthews C, Faugere MC, Fanti P, Endres DB, Friedler RM 1986 1,25-Dihydroxyvitamin D maintains bone cell activity, and parathyroid hormone modulates bone cell number in dogs. Endocrinology 119: 1298–1304.
- 26 Malluche HH, Faugere MC, Friedler RM, Fanti P 1988 1,25-Dihydroxyvitamin D3 corrects bone loss but suppresses bone remodeling in ovariohysterectomized beagle dogs. Endocrinology 122: 1998–2006.
- 27 Tsurukami H, Nakamura T, Suzuki K, Sato K, Higuchi Y, Nishii Y 1994 A novel synthetic vitamin D analogue, 2β-(3-hydroxypropoxy)1α,25-dihydroxyvitamin D, (ED-71), increases bone mass by stimulating the bone formation in normal and ovariectomized rats. Calcif Tissue Int 54: 142–149.
- 28 Ikeda T, Kohno H, Yamamuro T, Kasai R, Ohta S, Okumura H, Konishi J, Kikuchi H, Shigeno C 1992 The effect of active vitamin D3 analogs and dexamethasone on the expression of osteocalcin gene in rat tibiae in vivo. Biochem Biophys Res Commun 189: 1231–1235.
- 29 Gundberg CM, Hauschka PV, Lian JB, Gallop PM 1984 Osteocalcin, Isolation, characterization, and detection. Meth Enzymol 107: 516–544.
- 30 Katsumata T, Nakamura T, Ohnishi H, Sakurama T 1995 Intermittent cyclical etidronate treatment maintains the mass, structure and the mechanical property of bone in ovariectomized rats. J Bone Miner Res 10: 921–931.
- 31 Mosekilde L, Danielsen CC, Knudsen UB 1993 The effect of aging and ovariectomy on the vertebral bone mass and biomechanical properties of mature rats. Bone 14: 1–6.
- 32 Turner RT 1994 Cancellous bone turnover in growing rats: Time-dependent changes in association between calcein label and osteoblasts. J Bone Miner Res 9: 1419–1424.
- 33 Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Maccuche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of ASBMR Histomorphometry Committee. J Bone Miner Res 2: 595–610.
- 34 Frost HM 1983 Bone histomorphometry: Analysis of trabecular bone dynamics. In RR Recker (ed.) Bone Histomorphometry: Techniques and Interpretations. CRC Press, Boca Raton, Florida, pp. 109–131.
- 35 Lindgren JU, DeLuca HF 1983 Oral 1,25(OH)2D3: An effective prophylactic treatment for glucocorticoid osteopenia in rats. Calcif Tissue Int 35: 107–110.
- 36 Swissa-Sivan A, Statter M, Brooks GA, Azevedo J, Viguie C, Azoury R, Greenfield C, Oman S, Leichter I, Zinker BA, Menczel J 1992 Effect of swimming on prednisolone-induced osteoporosis in elderly rats. J Bone Miner Res 7: 161–169.
- 37 Baylink DJ 1983 Glucocorticoid-induced osteoporosis. New Engl J Med 309: 306–308.
- 38 Avioli LV 1984 Effects of chronic corticosteroid therapy on mineral metabolism and calcium absorption. Adv Exp Med Biol 171: 81–89.
- 39 Gennari C, Imbimbo B, Montagnani M, Bernini M, Nardi P, Avioli LV 1984 Effects of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans. Calcif Tissue Int 36: 245–252.
- 40 Gallagher JC, Aaron J, Horsman A, Wilkinson R, Nordin BEC 1973 Corticosteroid osteoporosis. Clin Endocrinol Metabol 2: 355–368.
- 41 Lund B, Storm TL, Lund B, Melsen F, Mosekilde L, Andersen RB, Egmose C, Sorensen OH 1985 Bone mineral loss, bone histomorphometry and vitamin D metabolism in patients with rheumatoid arthritis on long-term glucocorticoid treatment. Clin Rheumatol 4: 143–149.
- 42 Aaron JE, Francis RM, Peacock M, Makins NB 1989 Contrasting microanatomy of idiopathic and corticosteroid-induced osteoporosis. Clin Ortho 243: 294–305.
- 43 Eriksen EF 1986 Normal and pathological remodeling of human trabecular bone: Three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease. Endocrinol Rev 7: 379–408.
- 44 Lindgren JU, Merchant CR, DeLuca HF 1982 Effect of 1,25-dihydroxyvitamin D3 on osteopenia induced by prednisolone in adult rats. Calcif Tissue Int 34: 253–257.
- 45 Lindgren JU, Johnell O, DeLuca HF 1983 Studies of bone tissue in rats treated by prednisolone and 1,25-(OH)2D3. Clin Ortho 181: 264–268.
- 46 Sjoden GOJ, Johnell O, DeLuca HF, Lindgren JU 1984 Effects of 1αOHD2 on bone tissue. Studies of 1αOHD2 and 1αOHD3 in normal rats and in rats treated with prednisolone. Acta Endocrinol 106: 564–568.
- 47 Jowell PS, Epstein S, Fallon MD, Reinhardt TA, Ismail F 1987 1,25-Dihydroxyvitamin D3 modulates glucocorticoid-induced alteration in serum bone gla protein and bone histomorphometry. Endocrinology 120: 531–536.
- 48 Sato K, Nishii Y, Woodiel FN, Raisz LG 1993 Effects of two new vitamin D3 derivatives, 22-oxa-1α-25-dihydroxyvitamin D3 (OCT) and 2β-(3-hydroxypropoxy)-1α,25-dihydroxyvitamin D3 (ED-71), on bone metabolism in organ culture. Bone 14: 47–51.
- 49 Okano T, Tsugawa N, Masuda S, Takeuchi A, Kobayashi T, Takita Y, Nishii Y 1989 Regulatory activities of 2β-(3-hydroxypropoxy)-1α,25-dihydroxyvitamin D3, a novel synthetic vitamin D3 derivative, on calcium metabolism. Biochem Biophys Res Commun 163: 1444–1449.